DK51087D0 - Antihypercholesterolaemiske forbindelser - Google Patents

Antihypercholesterolaemiske forbindelser

Info

Publication number
DK51087D0
DK51087D0 DK051087A DK51087A DK51087D0 DK 51087 D0 DK51087 D0 DK 51087D0 DK 051087 A DK051087 A DK 051087A DK 51087 A DK51087 A DK 51087A DK 51087 D0 DK51087 D0 DK 51087D0
Authority
DK
Denmark
Prior art keywords
compounds
antihypercholesterolaemic
methylglutaryl
hmg
coenzyme
Prior art date
Application number
DK051087A
Other languages
English (en)
Other versions
DK51087A (da
Inventor
Robert L Smith
Gerald E Stokker
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK51087D0 publication Critical patent/DK51087D0/da
Publication of DK51087A publication Critical patent/DK51087A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK051087A 1986-01-31 1987-01-30 Antihypercholesterolaemiske forbindelser DK51087A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/824,900 US4772626A (en) 1986-01-31 1986-01-31 Antihypercholesterolemic compounds

Publications (2)

Publication Number Publication Date
DK51087D0 true DK51087D0 (da) 1987-01-30
DK51087A DK51087A (da) 1987-08-01

Family

ID=25242603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK051087A DK51087A (da) 1986-01-31 1987-01-30 Antihypercholesterolaemiske forbindelser

Country Status (7)

Country Link
US (1) US4772626A (da)
EP (1) EP0232997B1 (da)
JP (1) JPS62190144A (da)
AT (1) ATE56715T1 (da)
DE (1) DE3764967D1 (da)
DK (1) DK51087A (da)
ES (1) ES2029829T3 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855321A (en) * 1986-01-31 1989-08-08 Merck & Co., Inc. Antihypercholesterolemic compounds
US5169976A (en) * 1987-11-25 1992-12-08 Pfizer Inc. N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents
US4900754A (en) * 1987-12-21 1990-02-13 Rorer Pharmaceutical Corp. HMG-COA reductase inhibitors
US4939143A (en) * 1987-12-21 1990-07-03 Rorer Pharmaceutical Corporation Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
US4904691A (en) * 1987-12-21 1990-02-27 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US5001144A (en) * 1987-12-21 1991-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
US5001128A (en) * 1987-12-21 1991-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. HMG-COA reductase inhibitors
US4863957A (en) * 1987-12-21 1989-09-05 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US4876280A (en) * 1988-03-10 1989-10-24 Sandoz Pharm. Corp. Arylcyclohexane and arylcyclohexene analogs of mevalonolactone derivatives and their use
DE3818570A1 (de) * 1988-06-01 1989-12-21 Boehringer Mannheim Gmbh Neue 6-substituierte-4-hydroxy-tetrahydro-pyran -2-on-derivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen
US4916239A (en) * 1988-07-19 1990-04-10 Merck & Co., Inc. Process for the lactonization of mevinic acids and analogs thereof
NZ230121A (en) * 1988-08-29 1993-08-26 Squibb & Sons Inc Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels
US5506219A (en) * 1988-08-29 1996-04-09 E. R. Squibb & Sons, Inc. Pyridine anchors for HMG-CoA reductase inhibitors
DE3909378A1 (de) * 1989-03-22 1990-09-27 Bayer Ag Substituierte biphenyle
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
EP0445827B1 (en) * 1990-03-07 1996-09-25 Fujirebio Inc. 4-Hydroxytetrahydropyran-2-one derivatives useful as cholesterol and lipid reducing agents
WO1991013616A1 (en) * 1990-03-08 1991-09-19 Rorer International (Overseas) Inc. NOVEL HMG-CoA REDUCTASE INHIBITORS
US5089523A (en) * 1990-05-11 1992-02-18 E. R. Squibb & Sons, Inc. Fluorinated derivatives of mevinic acids
BRPI0721761A2 (pt) * 2007-05-29 2013-02-13 Evonik Degussa Gmbh hidrogenaÇço de compostos nitro hidrogenaÇço de aromÁticos nitrados hidrogenaÇço contÍnua de aromÁticos nitrados catalisadores de in ativado
US20210008084A1 (en) 2017-10-16 2021-01-14 Tsinghua University Mevalonate pathway inhibitor and pharmaceutical composition thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4459422A (en) * 1979-08-17 1984-07-10 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis

Also Published As

Publication number Publication date
EP0232997A1 (en) 1987-08-19
US4772626A (en) 1988-09-20
DK51087A (da) 1987-08-01
EP0232997B1 (en) 1990-09-19
JPS62190144A (ja) 1987-08-20
ATE56715T1 (de) 1990-10-15
DE3764967D1 (de) 1990-10-25
ES2029829T3 (es) 1992-10-01

Similar Documents

Publication Publication Date Title
DK51087D0 (da) Antihypercholesterolaemiske forbindelser
ES2000842A6 (es) Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
DK0599444T3 (da) Dobbeltvirkende inhibitorer
DK0595610T3 (da) Benzokondenserede lactamer
DE69133299D1 (de) Aminosulfonylcarbamate
IT1100945B (it) Composti diidrossiottaidrofenantrenici ad azione analgesica e loro intermedi
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
MX9301045A (es) Procedimiento para preparar antagonistas receptores de fibrinogeno.
ATE226210T1 (de) Phospholipidanaloge verbindungen
FI893004A0 (fi) 5-oxygenerade hmg-coa-reduktas -inhibitorer.
EP0245003A3 (en) Antihypercholesterolemic compounds
EP0245990A3 (en) Antihypercholesterolemic compounds
EP0397613A3 (en) Pharmacologically active aminoimidazopyridines
TR199802456T2 (xx) Yeni pirol t�revleri.
DE69405760D1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
DE3673657D1 (de) Oktahydroindolizine brauchbar als analgetika.
TW334428B (en) Novel benzodiazepine derivatives
ATE26268T1 (de) 2-alkoxyaminosulfonylbenzolsulfonyl-harnstoffderivate.
NO943230L (no) Naftoksaziner
DE69025817D1 (de) 3-Keto-HMG-CoA Reduktase-Inhibitoren
FI811424L (fi) Cykliska amider
FI956334A (fi) Farmakologisesti aktiivisia enantiomeereja
YU127289A (sh) INHIBITORI 5-OKSIGENISANE HMG-CoA REDUKTAZE
ES2162550A1 (es) Procedimiento de preparacion de 3-hidroximetilquinuclidina.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment